Acinar Cell Biology and Pancreatic Disease

腺泡细胞生物学和胰腺疾病

基本信息

  • 批准号:
    7033181
  • 负责人:
  • 金额:
    $ 28.74万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-03-08 至 2011-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The pivotal role of Ca2+ in regulating pancreatic acinar cell function under normal and pathophysiological conditions is well established, however, the molecular changes that occur in response to elevated Ca2+ are largely unknown. This proposal addresses a novel mechanism by which cytosolic Ca2+ modulates the trafficking of phospholipids and associated regulatory proteins in the secretory and endocytic pathways in acinar cells. Calcium responsive heat-stable protein (CRHSP-28) is a key regulatory molecule in the secretory pathway of acinar cells. CRHSP-28 is highly modulated by changes in cellular Ca2+ as indicated by its Ca2+-dependent 1) regulation of digestive enzyme secretion, 2) interaction with the vesicle trafficking protein annexin VI, and 3) serine phosphorylation, which triggers the release of CRHSP-28 from a membrane associated complex. The primary objective of this proposal is to test the hypothesis that CRHSP- 28 acts as Ca2+-sensor to promote and stabilize key protein interactions necessary for acinar cell membrane trafficking. In Specific Aim 1 experiments will address the concept that interaction of CRHSP-28 with annexin VI directs CRHSP-28 association with endosomes that are necessary to support secretory function. Site specific mutants targeting the annexin VI binding domain will be expressed in acini and effects on zymogen secretion and membrane trafficking determined. Specific Aim 2 will utilize CRHSP-28 mutants that alter the major CRHSP-28 phosphorylation site, serine 136, to test the theory that phosphorylation inhibits CRHSP-28 function by displacing it from a membrane-bound state. Specific Aim 3 will address the hypothesis that CRHSP-28 regulates an apical membrane trafficking pathway that is distinct from zymogen granules and acts to shuttle important regulatory molecules to the apical membrane. Elucidation of the molecular mechanism by which CRHSP-28 modulates exocrine function should provide valuable insight into the.Ca2+- dependent nature of the secretory pathway in acinar cells, which is essential for the development of therapeutic strategies aimed at the treatment of exocrine pancreatic disease. This proposal is aimed at understanding the biochemical mechanism by which changes in cell Ca2+ regulate pancreatic function in normal and pathological states. As such, these studies will help to identify potential targets for drug discovery and therapeutic strategies aimed at treating pancreatic disease.
描述(由申请人提供):在正常和病理生理条件下,Ca 2+在调节胰腺腺泡细胞功能中的关键作用已得到充分证实,然而,对Ca 2+升高的反应发生的分子变化在很大程度上尚不清楚。这一建议提出了一种新的机制,胞质钙离子调节运输的磷脂和相关的调节蛋白在腺泡细胞的分泌和内吞途径。钙应答热稳定蛋白(CRHSP-28)是腺泡细胞分泌途径中的关键调节分子。CRHSP-28受细胞Ca 2+变化的高度调节,如其Ca 2+依赖性1)消化酶分泌的调节,2)与囊泡运输蛋白膜联蛋白VI的相互作用,和3)丝氨酸磷酸化,其触发CRHSP-28从膜相关复合物的释放。该提案的主要目的是检验CRHSP- 28作为Ca 2+传感器促进和稳定腺泡细胞膜运输所需的关键蛋白相互作用的假设。在具体目标1中,实验将解决CRHSP-28与膜联蛋白VI的相互作用指导CRHSP-28与支持分泌功能所必需的内体缔合的概念。靶向膜联蛋白VI结合结构域的位点特异性突变体将在腺泡中表达,并确定对酶原分泌和膜运输的影响。具体目标2将利用CRHSP-28突变体,改变主要的CRHSP-28磷酸化位点,丝氨酸136,以测试磷酸化通过将其从膜结合状态置换来抑制CRHSP-28功能的理论。具体目标3将解决CRHSP-28调节顶膜运输途径的假设,该途径与酶原颗粒不同,并用于将重要的调节分子穿梭至顶膜。CRHSP-28调节外分泌功能的分子机制的阐明应该提供有价值的洞察腺泡细胞中分泌途径的Ca 2+依赖性,这对于旨在治疗外分泌胰腺疾病的治疗策略的发展是必不可少的。该建议旨在了解细胞Ca 2+变化在正常和病理状态下调节胰腺功能的生化机制。因此,这些研究将有助于确定旨在治疗胰腺疾病的药物发现和治疗策略的潜在靶点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GUY E GROBLEWSKI其他文献

GUY E GROBLEWSKI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GUY E GROBLEWSKI', 18)}}的其他基金

Role of the ER acetyl CoA transporter in alcoholic pancreatitis
ER 乙酰 CoA 转运蛋白在酒精性胰腺炎中的作用
  • 批准号:
    10358591
  • 财政年份:
    2021
  • 资助金额:
    $ 28.74万
  • 项目类别:
Role of the ER acetyl CoA transporter in alcoholic pancreatitis
ER 乙酰 CoA 转运蛋白在酒精性胰腺炎中的作用
  • 批准号:
    10582543
  • 财政年份:
    2021
  • 资助金额:
    $ 28.74万
  • 项目类别:
Acinar Biology and Pancreatic Disease
腺泡生物学和胰腺疾病
  • 批准号:
    9457119
  • 财政年份:
    2018
  • 资助金额:
    $ 28.74万
  • 项目类别:
Acinar Biology and Pancreatic Disease
腺泡生物学和胰腺疾病
  • 批准号:
    9921376
  • 财政年份:
    2018
  • 资助金额:
    $ 28.74万
  • 项目类别:
Acinar Biology and Pancreatic Disease
腺泡生物学和胰腺疾病
  • 批准号:
    8429457
  • 财政年份:
    2006
  • 资助金额:
    $ 28.74万
  • 项目类别:
Acinar Cell Biology and Pancreatic Disease
腺泡细胞生物学和胰腺疾病
  • 批准号:
    7221415
  • 财政年份:
    2006
  • 资助金额:
    $ 28.74万
  • 项目类别:
Acinar Cell Biology and Pancreatic Disease
腺泡细胞生物学和胰腺疾病
  • 批准号:
    7574589
  • 财政年份:
    2006
  • 资助金额:
    $ 28.74万
  • 项目类别:
Acinar Cell Biology and Pancreatic Disease
腺泡细胞生物学和胰腺疾病
  • 批准号:
    7367045
  • 财政年份:
    2006
  • 资助金额:
    $ 28.74万
  • 项目类别:
Acinar Biology and Pancreatic Disease
腺泡生物学和胰腺疾病
  • 批准号:
    8675844
  • 财政年份:
    2006
  • 资助金额:
    $ 28.74万
  • 项目类别:
Acinar Cell Biology and Pancreatic Disease
腺泡细胞生物学和胰腺疾病
  • 批准号:
    7197274
  • 财政年份:
    2006
  • 资助金额:
    $ 28.74万
  • 项目类别:

相似国自然基金

D型IC-8多肽修饰的还原敏感型RHB自组装双靶向核酸递送载体的研究
  • 批准号:
    81273459
  • 批准年份:
    2012
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目

相似海外基金

Diversification of Glomerular Kidney Disease Treatments By Targeting Therapeutics to the Kidney
通过针对肾脏的治疗来实现肾小球肾病治疗的多样化
  • 批准号:
    10808617
  • 财政年份:
    2023
  • 资助金额:
    $ 28.74万
  • 项目类别:
CLEC7A in microglia biology and Alzheimer's disease
CLEC7A 在小胶质细胞生物学和阿尔茨海默病中的作用
  • 批准号:
    10659940
  • 财政年份:
    2023
  • 资助金额:
    $ 28.74万
  • 项目类别:
Pathogenesis of renal injury and hypertension in HIV+ children
HIV儿童肾损伤和高血压的发病机制
  • 批准号:
    10700601
  • 财政年份:
    2023
  • 资助金额:
    $ 28.74万
  • 项目类别:
Validation and Improvement of ISPRI-HCP: An Innovative Platform for Immunogenicity Risk Assessment of Process-related Protein Impurities
ISPRI-HCP 的验证和改进:工艺相关蛋白质杂质免疫原性风险评估的创新平台
  • 批准号:
    10603538
  • 财政年份:
    2023
  • 资助金额:
    $ 28.74万
  • 项目类别:
Investigating the function and mechanism of interleukin 7 receptor-expressing pro-angiogenic macrophages during experimental choroidal neovascularization
研究表达白细胞介素7受体的促血管生成巨噬细胞在实验性脉络膜新生血管形成过程中的功能和机制
  • 批准号:
    10563645
  • 财政年份:
    2023
  • 资助金额:
    $ 28.74万
  • 项目类别:
Emerging role of tumor-derived exosomes in immune modulation and breast cancer health disparity.
肿瘤源性外泌体在免疫调节和乳腺癌健康差异中的新作用。
  • 批准号:
    10726647
  • 财政年份:
    2023
  • 资助金额:
    $ 28.74万
  • 项目类别:
Resilience mechanisms of Arctic ground squirrel neurons
北极地松鼠神经元的恢复机制
  • 批准号:
    10550125
  • 财政年份:
    2022
  • 资助金额:
    $ 28.74万
  • 项目类别:
Simultaneous Imaging of Tumor and Host Cells in the Microenvironment
微环境中肿瘤和宿主细胞的同步成像
  • 批准号:
    10387354
  • 财政年份:
    2022
  • 资助金额:
    $ 28.74万
  • 项目类别:
Resilience mechanisms of Arctic ground squirrel neurons
北极地松鼠神经元的恢复机制
  • 批准号:
    10363408
  • 财政年份:
    2022
  • 资助金额:
    $ 28.74万
  • 项目类别:
APC + TP53 Combinatorial Mutations Emerging as Biomarkers to Predict EGFRI Sensitivity
APC TP53 组合突变作为预测 EGFRI 敏感性的生物标志物
  • 批准号:
    10610600
  • 财政年份:
    2022
  • 资助金额:
    $ 28.74万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了